Human Genome Epidemiology Literature Finder
Records 1 - 2 (of 2 Records) |
Query Trace: Hyperbilirubinemia and EGFR[original query] |
---|
Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG-0803). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012 Nov . Wu YL, Zhou C, Cheng Y, Lu S, Chen GY, Huang C, Huang YS, Yan HH, Ren S, Liu Y, Yang JJ |
Hematological parameters in EGFR-mutated advanced NSCLC patients treated with TKIs: predicting survival and toxicity. Expert review of anticancer therapy 2021 Feb . Jokic Vera, Savic-Vujovic Katarina, Spasic Jelena, Stanic Nemanja, Marinkovic Mladen, Radosavljevic Davorin, Cavic Mile |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: